Five-year Outcome of Laparoscopic Gastric Sleeve

Five-year Outcome of Laparoscopic Gastric Sleeve, Resolution of Comorbidities and Risk for Cumulative Nutritional Deficiencies.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03467581

Enrollment

500

Registered

2018-03-16

Start date

2008-10-08

Completion date

2028-12-31

Last updated

2018-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric Surgeries, Metabolic Surgery

Keywords

gastric sleeve

Brief summary

The aim of this study is to evaluate the long-term (5-year follow-up) results of laparoscopic gastric sleeve (LGS) in terms of weight loss and obesity related comorbidities, as well as the risk factors associated with postoperative nutritional deficiencies.

Detailed description

The consecutive patients who undergo LGS for the treatment of morbid obesity at Tartu University Hospital are followed prospectively in cohort study. The outpatient hospital follow-up visits are conducted at 3 months, 1 year and 5 years postoperatively.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* The criteria for bariatric surgery: BMI of \>40, or \>35 with certain obesity related comorbidities

Exclusion criteria

* Patients who did not fill the inclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
Five-year outcome of laparoscopic gastric sleeve	5-year follow-up	5-year outcome in terms of weight loss, calculated in mean excess weight lost (%EWL).

Secondary

Measure	Time frame	Description
Five-year outcome of laparoscopic gastric sleeve	5-year follow-up	5-year outcome of resolution of obesity-related comorbidities (type 2 diabetes mellitus, hypertension, obstructive sleep apnea, dyslipidemia). Prevalence of comorbidities are presented in percentages. McNemar´s test is employed to analyse significance of resolution of comorbidities.

Countries

Estonia

Contacts

Primary ContactToomas Sillakivi, Dr, PhD

toomas.sillakivi@kliinikum.ee

Outcome results